Related Experiment Video
Updated: Jul 22, 2026
08:50
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.6K
Comparison of Robot-Assisted Multivessel Minimally Invasive Direct Coronary Artery Bypass and Hybrid
Zhandong Zhou1, Karikehalli A Dilip1, Anna Gleboff1
1Department of Cardiac Surgery, St Joseph's Health Hospital, Syracuse, New York.
Annals of Thoracic Surgery Short Reports
|January 10, 2025
Summary
Robot-assisted multivessel minimally invasive direct coronary artery bypass (MIDCAB) offers safe and complete revascularization. While the hybrid approach is preferred, robotic MIDCAB shows comparable outcomes and potentially more durable results for complex cases.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Techniques
- Robotic Surgery
Background:
- Comparing robot-assisted multivessel minimally invasive direct coronary artery bypass (MIDCAB) with a hybrid approach.
- Evaluating two strategies for coronary revascularization.
Purpose of the Study:
- To compare the safety and efficacy of robot-assisted multivessel MIDCAB versus a hybrid approach.
- To determine patient outcomes and complication rates for each revascularization strategy.
Main Methods:
- Retrospective review of robotic MIDCAB cases (2012-2022).
- Analysis of two patient groups: surgery (robotic multivessel MIDCAB) and hybrid (MIDCAB + PCI within 30 days).
- Comparison of patient demographics, postoperative complications, length of stay, and mortality.
Main Results:
- 105 patients in the surgery group, 81 in the hybrid group; similar characteristics except older patients in the surgery group.
- No mortalities in either group.
- Higher postoperative atrial fibrillation rates in the surgery group; no significant differences in length of stay or other complications.
Conclusions:
- Multivessel robotic MIDCAB is safe with outcomes comparable to the hybrid approach.
- The hybrid technique is less demanding and preferred in most centers.
- Robotic MIDCAB provides complete revascularization and potentially more durable results, especially for complex non-LAD lesions unsuitable for the hybrid approach.
